Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

Journal of the Formosan Medical Association

Volumn 108, Issue 11, 2009, Pages 872-878

  Ho, Chen Hsun ^a,b   Huang, Chao Yuan ^a   Lin, Wei Chou ^c   Chueh, Shih Chieh ^a   Pu, Yeong Shiau ^a   Lai, Ming Kuen ^a   Yu, Hong Jeng ^a   Huang, Kuo How ^a  

^a Department of Urology ^*  (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

bladder cancer; cystectomy; lymph nodes; neoplasm metastasis; survival

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER MORTALITY; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROSTATE CANCER; RECURRENCE RISK;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 71649087105     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60419-8     Document Type: Article

References (16)

1. Bureau of Health Promotion, Executive Yuan, Taiwan, R.O.C. Cancer Registry Annual Report, 2005. Taipei: Bureau of Health Promotion, Department of Health, Executive Yuan, Taiwan, R.O.C.
2. American Joint Committee on Cancer. Cancer Staging Manual. 5th ed. (1997), Lippincott-Raven, Philadelphia 241
3. Herr H.W., Dotan Z., Donat S.M., et al. Defining optimal therapy for muscle invasive bladder cancer. J Urol 177 (2007) 437-443
4. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
5. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361 (2003) 1927-1934
6. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
7. Herr H.W., Faulkner J.R., Grossman H.B., et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22 (2004) 2781-2789
8. Herr H.W. The concept of lymph node density: is it ready for clinical practice?. J Urol 177 (2007) 1273-1276
9. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
10. Steven K., and Poulsen A.L. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 178 (2007) 1214-1218
11. Poulsen A.L., Horn T., and Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160 (1998) 2015-2020
12. Daughtry J.D., Susan L.P., Stewart B.H., et al. Ileal conduit and cystectomy: a 10-year retrospective study of ileal conduits performed in conjunction with cystectomy and with a minimum 5-year followup. J Urol 118 (1977) 556-557
13. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149 (1993) 755-758
14. Vieweg J., Whitmore Jr. W.F., Herr H.W., et al. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan- Kettering Cancer Center experience. Cancer 73 (1994) 3020-3028
15. Vieweg J., Gschwend J.E., Herr H.W., et al. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161 (1999) 449-454
16. Yang C.R., Ou Y.C., Ho H.C., et al. Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy. Mol Urol 3 (1999) 33-39